Menu

Smartphone Diagnostic

Researchers design a device that attaches to a smartphone to test for diverse infectious diseases from a drop of blood.

Feb 5, 2015
Jef Akst

A smartphone dongle with a disposable microfluidic cassetteTASSANEEWAN LAKSANASOPINA push of a button vacuums up a drop of blood from a finger prick, and in just 15 minutes, the device can determine if a person is infected with any of a variety of infectious diseases. The new device, developed by Columbia University’s Samuel Sia and colleagues, is designed to be hooked up to a smartphone, which provides a power source and a display for the results. Published yesterday (February 4) in Science Translational Medicine, the technology is the latest effort in smartphone diagnostics, which could bring improved health care to underdeveloped parts of the world.

The new device, which costs just $34, functions by drawing the blood sample through tiny channels containing “detection zones” designed to find antibodies in the blood suggestive of a particular pathogen’s presence. In a field test held at three Rwandan community clinics, health care workers screened patients for HIV and syphilis with 96-percent accuracy. The team is now planning a larger trial, Science reported.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.